当前位置:首页 - 行情中心 - 仙琚制药(002332) - 财务分析 - 现金流量表

仙琚制药

(002332)

  

流通市值:91.66亿  总市值:92.09亿
流通股本:9.85亿   总股本:9.89亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,505,196,638.791,696,576,041.96758,022,233.963,465,941,898.04
  收到的税费返还4,340,908.054,285,265.74,155,449.96-
  收到其他与经营活动有关的现金72,307,196.3649,004,951.1347,248,603.97173,434,196.5
  经营活动现金流入小计2,581,844,743.21,749,866,258.79809,426,287.893,639,376,094.54
  购买商品、接受劳务支付的现金523,816,843.06372,594,898.48193,868,509.571,133,796,704.77
  支付给职工以及为职工支付的现金558,262,951.85401,830,500.55193,980,403.96730,928,558.28
  支付的各项税费244,113,020.79167,749,08979,196,674.94254,063,557.57
  支付其他与经营活动有关的现金1,128,140,631.93808,021,756.31323,958,967.41,121,931,898.53
  经营活动现金流出小计2,454,333,447.631,750,196,244.34791,004,555.873,240,720,719.15
  经营活动产生的现金流量净额127,511,295.57-329,985.5518,421,732.02398,655,375.39
二、投资活动产生的现金流量:
  收回投资收到的现金---16,000,000
  取得投资收益收到的现金2,205,000--4,205,000
  处置固定资产、无形资产和其他长期资产收回的现金净额340,201.4123,662.666,405.3447,260,213.44
  投资活动现金流入小计2,545,201.4123,662.666,405.3467,465,213.44
  购建固定资产、无形资产和其他长期资产支付的现金166,336,311.27136,330,874.2769,740,347.25207,586,758.86
  投资支付的现金290,909290,909-40,300,000
  投资活动现金流出小计166,627,220.27136,621,783.2769,740,347.25247,886,758.86
  投资活动产生的现金流量净额-164,082,018.86-136,598,120.61-69,733,941.91-180,421,545.42
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,350,000900,000900,000-
  其中:子公司吸收少数股东投资收到的现金1,350,000900,000900,000-
  取得借款收到的现金329,000,000321,500,0009,306,279.635,618,396.29
  收到其他与筹资活动有关的现金6,533,205.136,533,205.13-3,450,890.5
  筹资活动现金流入小计336,883,205.13328,933,205.1310,206,279.639,069,286.79
  偿还债务支付的现金114,804,483.396,385,092.814,925,553.7169,530,998.18
  分配股利、利润或偿付利息支付的现金301,318,050.26300,127,420.42148,326.07300,191,071.46
  其中:子公司支付给少数股东的股利、利润2,000,0002,000,000-2,000,000
  支付其他与筹资活动有关的现金5,379,487.253,308,865.81-5,172,073.01
  筹资活动现金流出小计421,502,020.9309,821,379.045,073,879.77474,894,142.65
  筹资活动产生的现金流量净额-84,618,815.7719,111,826.095,132,399.86-465,824,855.86
四、汇率变动对现金及现金等价物的影响41,513,544.6342,751,638.3824,611,399.83-6,127,786.58
五、现金及现金等价物净增加额-79,675,994.43-75,064,641.69-21,568,410.2-253,718,812.47
  加:期初现金及现金等价物余额1,376,132,147.751,376,132,147.751,376,132,147.751,629,850,960.22
  期末现金及现金等价物余额1,296,456,153.321,301,067,506.061,354,563,737.551,376,132,147.75
补充资料:
  净利润-296,096,657.34-399,923,214.68
  资产减值准备-29,152,050.72-54,955,757.75
  固定资产和投资性房地产折旧-104,519,024.44-201,413,905.58
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-104,519,024.44-201,413,905.58
  无形资产摊销-10,609,292.26-18,896,169.57
  长期待摊费用摊销-1,464,705.57-1,925,043.04
  处置固定资产、无形资产和其他长期资产的损失--46,212,235.3--283,085.44
  固定资产报废损失-888,061.12-1,314,141.84
  财务费用-3,724,010.57--7,442,068.23
  投资损失-9,438,418.86-8,080,022.4
  递延所得税--3,512,637.94--7,141,088.95
  其中:递延所得税资产减少--3,512,637.94--7,141,088.95
  存货的减少--54,828,485.2--88,142,337.37
  经营性应收项目的减少--152,345,545.9--280,879,215.87
  经营性应付项目的增加--201,285,441.7-89,600,356.74
  现金的期末余额-1,301,067,506.06-1,376,132,147.75
  减:现金的期初余额-1,376,132,147.75-1,629,850,960.22
  现金及现金等价物的净增加额--75,064,641.69--253,718,812.47
公告日期2025-10-282025-08-272025-04-242025-04-24
审计意见(境内)标准无保留意见
TOP↑